Eye For Pharma - beyond Multi-Channel
•Download as PPTX, PDF•
3 likes•727 views
Presentation from eyeforpharma multichannel conference. The meeting was took place 7 & 8 November 2013 in London. The presentation focused on moving beyond the traditional pharmaceutical initiatives to look at how start-ups and the quantified self movement are changing healthcare faster than before.
Report
Share
Report
Share
Recommended
Best of the Web V. III
This document lists the sites and reviews for 22 tools for creating presentations and slide shows. Each entry provides the site URL and a link to a review blog post for tools like Ahead, Creaza, Digital Vaults, Flixtime, Glogster, KickLight, Kioza, Magic Studio, Magnoto, Me and My Movie, Museum Box, My Hero, One True Media, Pho.to, PhotoPeach, PhotoSnack, Prezi, Shwup, Slideroll and Vuvox.
'Prototyping' - GSJ11 Seoul
This document contains a list of links related to various types of prototyping methods including paper prototyping, photo prototyping, storyboarding, experience prototyping, and wizard of oz testing. The links provide additional information about each prototyping technique and how they can be used to test and refine designs before development.
ベジェ曲線を書いてみた
This document provides biographical information about Hiromu Shioya, including details about his work with Kwappa, a company focused on web development, as well as links to their website and recruitment page. It also includes links to Kwappa's work on a renderer and GitHub's mascot website.
Wakelet 03.12.2019
#WakeletWave - Webinar auf DE fuer die eTwinning Gruppe: "Projekte auf Deutsch - Webinare/ Projekt-Börse" - 03.12.2019
Incomplete file
The document contains a list of 15 URLs from various websites and services including Google+, Wufoo, Zotero, StumbleUpon, Yola, Beep, WordPress, Delicious, Gravatar, Flavors.me, Sitew, Techdirt, Blogger, Jimdo, and Magnt. The URLs provide links to profiles, blog posts, and shared content related to the name "priyabrata9" or "priyabrataswain99" on those platforms.
50sites ver2
The document lists over 50 websites for creating digital content across various categories such as audio, charts/graphs, digital art, digital storytelling, and presentations. Each entry includes the site's URL and a link to a review of the site on the author's blog. The document serves as a reference guide for finding online tools to support creating different types of digital content.
50sites ver2-110525105847-phpapp01
The document lists over 50 websites for creating digital content across various categories such as audio, charts/graphs, digital art, digital storytelling, presentations, and search engines. Each entry includes the site's URL and a link to a review of the site on the author's blog. The document serves as a reference guide for finding online tools to support creating different types of digital content.
Velocity the future of pharma
My presentation from Velocity. I spoke about the healthcare industry and how the quantified self movement is shaping new opportunities.
Recommended
Best of the Web V. III
This document lists the sites and reviews for 22 tools for creating presentations and slide shows. Each entry provides the site URL and a link to a review blog post for tools like Ahead, Creaza, Digital Vaults, Flixtime, Glogster, KickLight, Kioza, Magic Studio, Magnoto, Me and My Movie, Museum Box, My Hero, One True Media, Pho.to, PhotoPeach, PhotoSnack, Prezi, Shwup, Slideroll and Vuvox.
'Prototyping' - GSJ11 Seoul
This document contains a list of links related to various types of prototyping methods including paper prototyping, photo prototyping, storyboarding, experience prototyping, and wizard of oz testing. The links provide additional information about each prototyping technique and how they can be used to test and refine designs before development.
ベジェ曲線を書いてみた
This document provides biographical information about Hiromu Shioya, including details about his work with Kwappa, a company focused on web development, as well as links to their website and recruitment page. It also includes links to Kwappa's work on a renderer and GitHub's mascot website.
Wakelet 03.12.2019
#WakeletWave - Webinar auf DE fuer die eTwinning Gruppe: "Projekte auf Deutsch - Webinare/ Projekt-Börse" - 03.12.2019
Incomplete file
The document contains a list of 15 URLs from various websites and services including Google+, Wufoo, Zotero, StumbleUpon, Yola, Beep, WordPress, Delicious, Gravatar, Flavors.me, Sitew, Techdirt, Blogger, Jimdo, and Magnt. The URLs provide links to profiles, blog posts, and shared content related to the name "priyabrata9" or "priyabrataswain99" on those platforms.
50sites ver2
The document lists over 50 websites for creating digital content across various categories such as audio, charts/graphs, digital art, digital storytelling, and presentations. Each entry includes the site's URL and a link to a review of the site on the author's blog. The document serves as a reference guide for finding online tools to support creating different types of digital content.
50sites ver2-110525105847-phpapp01
The document lists over 50 websites for creating digital content across various categories such as audio, charts/graphs, digital art, digital storytelling, presentations, and search engines. Each entry includes the site's URL and a link to a review of the site on the author's blog. The document serves as a reference guide for finding online tools to support creating different types of digital content.
Velocity the future of pharma
My presentation from Velocity. I spoke about the healthcare industry and how the quantified self movement is shaping new opportunities.
The future of digital healthcare
A presentation I made at the House of Lords on the future of digital heathcare looking at future technologies and those more immediate that can change patients outcomes
Integrating digital, communications and marketing
My presentation from PR Moments in May 2015. The presentation is about how to integrate digital, communications, public relations and marketing with large scale, enterprise organisations. There is information on the pitfalls and opportunities with integration and I highlight two marketing models I use - RACE and POEM.
Solving the customer / user problem and building an integrated strategy to su...
A presenation from Digital Pharma Advances (London 2015) where I presented on understanding the the problem you are trying to solve, then building your strategy from there. Too often we start with the solution and seek to fix a problem with it, which causes friction.
What to wear. Wearable technologies, marketing opportunities and pitfals
A presentation I made at Apps World London (13th November 2014) around the rise of wearable technologies and the predicted growth. I cover the marketing opportunities and pitfalls especially around devices, technologies, platforms, differing connected health platforms etc.
Considerations for a global healthcare patient engagement programme
Leading a global healthcare patient engagement programme can be one of the most rewarding activities however from the perspective of a pharmaceutical company, it can be fraught with issues. This presentation gives a few areas of consideration for those setting out down this path. Compliance, legal, regulations are all areas we typically know but how many people consider localisation, technologies, demographics and ultimately the patient need for support.
Velocity and the shift to adaptive, contextual content online
We have moved from static web pages to semi-personalised but we now are facing a future of contextual information, based upon our location, environment etc. Personalised content goes beyond just adding the users name at the top, it goes down to micro-content being assembled in real-time to support the user.
This presentation for the medical / legal / regulatory teams in the pharmaceutical industry tries to show the shift in where we've come from to where we need to go to. Pharma typically lags behind due to uncertainty in the regulatory constraints, however the biggest constraint in the mindset for not doing this. Everything is possible.
The last few slides are there to indicate the shift in healthcare through technology - just a bit of fun.
Developing insights to understand customer needs before engaging your custome...
My presentation from Digital Pharma Advances, London, 2014 on how to engage your customers using digital channels. The theme was to return to simple marketing principles, the refocus on the sweet spot of customer & business needs. Another key element was to use what data you already have and don't think you have to start from scratch.
Healthcare Communications Association - Digital Day 2013
A presentation on the pharmacetuical industries approach to digital marketing and where the future opportunity may lie.
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
vertical loop
horizontal loop
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
More Related Content
More from Kai Gait
The future of digital healthcare
A presentation I made at the House of Lords on the future of digital heathcare looking at future technologies and those more immediate that can change patients outcomes
Integrating digital, communications and marketing
My presentation from PR Moments in May 2015. The presentation is about how to integrate digital, communications, public relations and marketing with large scale, enterprise organisations. There is information on the pitfalls and opportunities with integration and I highlight two marketing models I use - RACE and POEM.
Solving the customer / user problem and building an integrated strategy to su...
A presenation from Digital Pharma Advances (London 2015) where I presented on understanding the the problem you are trying to solve, then building your strategy from there. Too often we start with the solution and seek to fix a problem with it, which causes friction.
What to wear. Wearable technologies, marketing opportunities and pitfals
A presentation I made at Apps World London (13th November 2014) around the rise of wearable technologies and the predicted growth. I cover the marketing opportunities and pitfalls especially around devices, technologies, platforms, differing connected health platforms etc.
Considerations for a global healthcare patient engagement programme
Leading a global healthcare patient engagement programme can be one of the most rewarding activities however from the perspective of a pharmaceutical company, it can be fraught with issues. This presentation gives a few areas of consideration for those setting out down this path. Compliance, legal, regulations are all areas we typically know but how many people consider localisation, technologies, demographics and ultimately the patient need for support.
Velocity and the shift to adaptive, contextual content online
We have moved from static web pages to semi-personalised but we now are facing a future of contextual information, based upon our location, environment etc. Personalised content goes beyond just adding the users name at the top, it goes down to micro-content being assembled in real-time to support the user.
This presentation for the medical / legal / regulatory teams in the pharmaceutical industry tries to show the shift in where we've come from to where we need to go to. Pharma typically lags behind due to uncertainty in the regulatory constraints, however the biggest constraint in the mindset for not doing this. Everything is possible.
The last few slides are there to indicate the shift in healthcare through technology - just a bit of fun.
Developing insights to understand customer needs before engaging your custome...
My presentation from Digital Pharma Advances, London, 2014 on how to engage your customers using digital channels. The theme was to return to simple marketing principles, the refocus on the sweet spot of customer & business needs. Another key element was to use what data you already have and don't think you have to start from scratch.
Healthcare Communications Association - Digital Day 2013
A presentation on the pharmacetuical industries approach to digital marketing and where the future opportunity may lie.
More from Kai Gait (8)
Solving the customer / user problem and building an integrated strategy to su...
Solving the customer / user problem and building an integrated strategy to su...
What to wear. Wearable technologies, marketing opportunities and pitfals
What to wear. Wearable technologies, marketing opportunities and pitfals
Considerations for a global healthcare patient engagement programme
Considerations for a global healthcare patient engagement programme
Velocity and the shift to adaptive, contextual content online
Velocity and the shift to adaptive, contextual content online
Developing insights to understand customer needs before engaging your custome...
Developing insights to understand customer needs before engaging your custome...
Healthcare Communications Association - Digital Day 2013
Healthcare Communications Association - Digital Day 2013
Recently uploaded
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
It includes regulation of combination products and medical devices. FDA and industry liaisons.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Top Effective Soaps for Fungal Skin Infections in India
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
vertical loop
horizontal loop
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Recently uploaded (20)
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
REGULATION FOR COMBINATION PRODUCTS AND MEDICAL DEVICES.pptx
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
LOOPS in orthodontics t loop bull loop vertical loop mushroom loop stop loop
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Eye For Pharma - beyond Multi-Channel
- 1. @kaigait